CASP1 and congenital myasthenic syndrome: The significant increase in active IL-1β forms and IL-1β mRNA in the hippocampus of CMS implied that there is a possibility for caspase-1 to be activated in the brain, which was justified by the increase of active caspase-1 form (p10).